Cargando…
Splice-switching antisense oligonucleotides as therapeutic drugs
Splice-switching oligonucleotides (SSOs) are short, synthetic, antisense, modified nucleic acids that base-pair with a pre-mRNA and disrupt the normal splicing repertoire of the transcript by blocking the RNA–RNA base-pairing or protein–RNA binding interactions that occur between components of the s...
Autores principales: | Havens, Mallory A., Hastings, Michelle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001604/ https://www.ncbi.nlm.nih.gov/pubmed/27288447 http://dx.doi.org/10.1093/nar/gkw533 |
Ejemplares similares
-
Managing the sequence-specificity of antisense oligonucleotides in drug discovery
por: Hagedorn, Peter H., et al.
Publicado: (2017) -
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
por: Juliano, Rudy, et al.
Publicado: (2008) -
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
por: Shen, Xiulong, et al.
Publicado: (2018) -
The delivery of therapeutic oligonucleotides
por: Juliano, Rudolph L.
Publicado: (2016) -
Target mRNA inhibition by oligonucleotide drugs in man
por: Lightfoot, Helen L., et al.
Publicado: (2012)